Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Expert Opinion on Therapeutic Patents|April 15, 2023
Antimalarial drugs: what's new in the patents?Elizabeth A Lopes, Maria M M Santos, Mattia MoriEuropean Journal of Medicinal Chemistry|July 17, 2026
Drugging p53 mutants: Recent advances using small-molecule modulation strategiesElizabeth A Lopes, Tomás G Monteiro, Maria M M SantosCurrent Medicinal Chemistry|November 17, 2018
Small Molecules Targeting Mutant P53: A Promising Approach for Cancer TreatmentElizabeth A Lopes, Sara Gomes, Lucília Saraiva, et al.Current Topics in Medicinal Chemistry|June 6, 2018
An Update on MDMX and Dual MDM2/X InhibitorsMargarida Espadinha, Valentina Barcherini, Elizabeth A Lopes, et al.RSC Medicinal Chemistry|September 21, 2023
Hybrid molecules of protoflavones and spirooxindole derivatives with selective cytotoxicity against triple-negative breast cancer cellsGábor Girst, Elizabeth A Lopes, Lídia M Gonçalves, et al.Chemmedchem|August 2, 2020
Potency and Selectivity Optimization of Tryptophanol-Derived Oxazoloisoindolinones: Novel p53 Activators in Human Colorectal CancerValentina Barcherini, Joana Almeida, Elizabeth A Lopes, et al.European Journal of Medicinal Chemistry|April 7, 2022
Discovery of spirooxadiazoline oxindoles with dual-stage antimalarial activityElizabeth A Lopes, Raquel Mestre, Diana Fontinha, et al.Pharmacological Research|December 10, 2021
Mutant p53 reactivator SLMP53-2 hinders ultraviolet B radiation-induced skin carcinogenesisJoana B Loureiro, Rita Ribeiro, Nair Nazareth, et al.European Journal of Medicinal Chemistry|August 12, 2022
Discovery of MDM2-p53 and MDM4-p53 protein-protein interactions small molecule dual inhibitorsMargarida Espadinha, Elizabeth A Lopes, Vanda Marques, et al.Pageof 1